SNCA and Parkinson disease: Parkinson’s Disease (PD) is a progressive and chronic neurodegenerative condition, characterized by the degeneration of dopaminergic neurons, the occurrence of alpha-synuclein (α-Syn)-enriched Lewy bodies in the brain, as well as neuroinflammation affecting motor system [1, 2].